Pembrolizumab-associated inflammatory myopathy

Rheumatology (Oxford). 2018 Feb 1;57(2):397-398. doi: 10.1093/rheumatology/kex346.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Antibodies, Monoclonal, Humanized / adverse effects*
  • Antineoplastic Agents, Immunological / adverse effects*
  • Antirheumatic Agents / adverse effects
  • Arthritis, Rheumatoid / drug therapy*
  • Etanercept / adverse effects
  • Fatal Outcome
  • Female
  • Humans
  • Melanoma / chemically induced
  • Melanoma / drug therapy*
  • Methotrexate / adverse effects
  • Myositis / chemically induced*

Substances

  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents, Immunological
  • Antirheumatic Agents
  • pembrolizumab
  • Etanercept
  • Methotrexate